1 – 30 of 30
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Proteogenomics decodes the evolution of human ipsilateral breast cancer
(
- Contribution to journal › Article
-
Mark
Combining histological grade, TILs, and the PD-1/PD-L1 pathway to identify immunogenic tumors and de-escalate radiotherapy in early breast cancer : A secondary analysis of a randomized clinical trial
(
- Contribution to journal › Article
-
Mark
Development and Validation of a Genomic Profile for the Omission of Local Adjuvant Radiation in Breast Cancer
(
- Contribution to journal › Article
-
Mark
Reply to V. Nardone et al
(
- Contribution to journal › Debate/Note/Editorial
- 2022
-
Mark
Androgen receptor reprogramming demarcates prognostic, context-dependent gene sets in primary and metastatic prostate cancer
(
- Contribution to journal › Article
-
Mark
The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
(
- Contribution to journal › Article
-
Mark
Breast cancer hypoxia in relation to prognosis and benefit from radiotherapy after breast-conserving surgery in a large, randomised trial with long-term follow-up
(
- Contribution to journal › Article
- 2021
-
Mark
Proteogenomic Workflow Reveals Molecular Phenotypes Related to Breast Cancer Mammographic Appearance
(
- Contribution to journal › Article
- 2020
-
Mark
Expression of HGF, pMet, and pAkt is related to benefit of radiotherapy after breast-conserving surgery : a long-term follow-up of the SweBCG91-RT randomised trial
(
- Contribution to journal › Article
-
Mark
Plasma membrane expression of G protein-coupled estrogen receptor (GPER)/G protein-coupled receptor 30 (GPR30) is associated with worse outcome in metachronous contralateral breast cancer
(
- Contribution to journal › Article
-
Mark
Comprehensive transcriptomic profiling identifies breast cancer patients who may be spared adjuvant systemic therapy
(
- Contribution to journal › Article
- 2019
-
Mark
The estrogen receptor coactivator AIB1 is a new putative prognostic biomarker in ER-positive/HER2-negative invasive lobular carcinoma of the breast
(
- Contribution to journal › Article
-
Mark
Effect of Radiotherapy After Breast-Conserving Surgery Depending on the Presence of Tumor-Infiltrating Lymphocytes : A Long-Term Follow-Up of the SweBCG91RT Randomized Trial
(
- Contribution to journal › Article
-
Mark
Clinicogenomic radiotherapy classifier predicting the need for intensified locoregional treatment after breast-conserving surgery for early-stage breast cancer
(
- Contribution to journal › Article
- 2018
-
Mark
Identification and validation of single-sample breast cancer radiosensitivity gene expression predictors
(
- Contribution to journal › Article
-
Mark
High-throughput molecular techniques and personalized treatment for primary breast cancer
2018)(
- Thesis › Doctoral thesis (compilation)
- 2017
-
Mark
TOP2A and EZH2 provide early detection of an aggressive prostate cancer subgroup
(
- Contribution to journal › Article
-
Mark
Response to radiotherapy after breast-conserving surgery in different breast cancer subtypes in the Swedish Breast Cancer Group 91 radiotherapy randomized clinical trial
(
- Contribution to journal › Article
-
Mark
AIB1 is a new putative prognostic biomarker in the luminal A and B-like (HER2-negative) classification of invasive lobular carcinoma
(
- Contribution to conference › Abstract
- 2016
-
Mark
Cancer associated proteins in blood plasma : Determining normal variation
(
- Contribution to journal › Article
- 2015
-
Mark
Remarkable similarities of chromosomal rearrangements between primary human breast cancers and matched distant metastases as revealed by whole-genome sequencing.
(
- Contribution to journal › Article
-
Mark
A Combined Shotgun and Targeted Mass Spectrometry Strategy for Breast Cancer Biomarker Discovery
(
- Contribution to journal › Article
-
Mark
Stem cell biomarker ALDH1A1 in breast cancer shows an association with prognosis and clinicopathological variables that is highly cut-off dependent.
(
- Contribution to journal › Article
-
Mark
Changes in glycoprotein expression between primary breast tumour and synchronous lymph node metastases or asynchronous distant metastases.
(
- Contribution to journal › Article
-
Mark
Whole genome sequencing of primary breast cancers and matched distant metastases
2015) American Association for Cancer Research (AACR) 106th Annual Meeting 2015 In Cancer Research 75(15).(
- Contribution to journal › Published meeting abstract
- 2014
-
Mark
Lack of G protein-coupled estrogen receptor (GPER) in the plasma membrane is associated with excellent long-term prognosis in breast cancer.
(
- Contribution to journal › Article
-
Mark
G protein-coupled estrogen receptor in the plasma membrane is prognostic in early breast cancer
(
- Contribution to journal › Published meeting abstract
-
Mark
Abstract P2-10-07: Stem cell marker aldehyde dehydrogenase 1 in stromal cells strongly correlates with prognosis in breast cancer
(
- Contribution to journal › Published meeting abstract
- 2013
-
Mark
G protein-coupled estrogen receptor is apoptotic and correlates with increased distant disease-free survival of estrogen receptor-positive breast cancer patients.
(
- Contribution to journal › Article
- 2011
-
Mark
P4-09-02: G Protein-Coupled Estrogen Receptor 1 Positively Correlates with Estrogen Receptor a Expression and Increased Distant Disease-Free Survival of Breast Cancer Patients.
(
- Contribution to journal › Published meeting abstract